title: The effects of the morphine analogue levorphanol on leukocytes. Metabolic effects at rest and during phagocytosis.
abstract: Studies on bacteria have suggested that morphine-like drugs have effects on the cell membrane. To determine the effect of this class of drugs on a mammalian cell, we selected the rabbit peritoneal exudate granulocyte, which undergoes striking membrane changes during phagocytosis. We examined the effect in vitro of the morphine analogue, levorphanol on phagocytosis and metabolism by granulocytes incubated with and without polystyrene particles or live Escherichia coli. Levorphanol (1 or 2 mmoles/liter) decreased: (a) acylation of lysolecithin or lysophosphatidylethanolamine in the medium (which is stimulated about two-fold during phagocytosis) both at rest (40%) and during phagocytosis (60%); (b) uptake of latex particles and Escherichia coli, as judged by electron microscopy; (c) killing of live Escherichia coli (10-fold); (d) (14)CO(2) production from glucose-1-(14)C during phagocytosis by at least 80%; (e) K(+) content of granulocytes (35%); (f) oxidation of linoleate-1-(14)C by 50%, and its incorporation into triglyceride by more than 80%. However, levorphanol stimulated 2 to 3-fold the incorporation of linoleate-1-(14)C or palmitate-1-(14)C into several phospholipids. Glucose uptake, lactate production, and adenosine triphosphate (ATP) content are not affected by the drug. Thus, levorphanol does not appear to exert its effects through generalized metabolic suppression. Removal of levorphanol by twice resuspending the granulocytes completely reverses all inhibition. In line with observations on bacteria, it appears that the complex effects of levorphanol on granulocytes may be due at least in part to an effect on the cell membrane.
mesh_terms: D000818:Animals; D002245:Carbon Dioxide / Q000378:metabolism; D002247:Carbon Isotopes; D002462:Cell Membrane / Q000187:drug effects; D003864:Depression, Chemical; D004926:Escherichia coli; D005947:Glucose / Q000378:metabolism; D066298:In Vitro Techniques; D007773:Lactates / Q000096:biosynthesis; D007962:Leukocytes / Q000166:cytology* / Q000378:metabolism*; D007981:Levorphanol / Q000494:pharmacology*; D008041:Linoleic Acids / Q000378:metabolism; D008244:Lysophosphatidylcholines / Q000378:metabolism*; D010169:Palmitic Acids / Q000378:metabolism; D010587:Phagocytosis; D010710:Phosphates / Q000378:metabolism; D010713:Phosphatidylcholines / Q000096:biosynthesis; D010714:Phosphatidylethanolamines / Q000096:biosynthesis; D011137:Polystyrenes; D011188:Potassium / Q000097:blood; D011817:Rabbits; D013778:Tetrazolium Salts / Q000378:metabolism
chemical_list: D002247:Carbon Isotopes; D007773:Lactates; D008041:Linoleic Acids; D008244:Lysophosphatidylcholines; D010169:Palmitic Acids; D010710:Phosphates; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D011137:Polystyrenes; D013778:Tetrazolium Salts; D002245:Carbon Dioxide; D007981:Levorphanol; D005947:Glucose; D011188:Potassium